HOW DO GLUCOCORTICOIDS, BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS AND DISEASE ACTIVITY IMPACT THE RISK OF STAPHYLOCOCCUS AUREUS BACTEREMIA IN RHEUMATOID ARTHRITIS PATIENTS? A NATIONWIDE NESTED CASE CONTROL STUDY IN THE DANISH DANBIO COHORT

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 223 KB, PDF-dokument

OriginalsprogEngelsk
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind81
Sider (fra-til)571
Antal sider1
ISSN0003-4967
DOI
StatusUdgivet - 2022

ID: 323832810